First interventional exchange of a left transvenous phrenic nerve stimulation lead from the novel remedē system.

J Cardiovasc Electrophysiol

Clinic for Thoracic and Cardiovascular Surgery, Herz- und Diabeteszentrum NRW, Ruhr, Universität Bochum, Bad Oeynhausen, Germany.

Published: November 2020

The remedē system is a novel fully implantable transvenous phrenic nerve stimulation (TPNS) device developed to treat central sleep apnea. No information is published on how to explant or replace its leads. An eighty-one year-old had a fractured lead and we removed it over a wire. However, unbreachable resistances occurred with a new lead deployed over the enclosed wire and interventional endovascular techniques were performed to reimplant a new fully functioning system. This first report demonstrates TPNS lead exchange is possible but can be challenging. Interventional maneuvers and techniques, including balloon angioplasty, can facilitate this procedure.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jce.14725DOI Listing

Publication Analysis

Top Keywords

transvenous phrenic
8
phrenic nerve
8
nerve stimulation
8
remedē system
8
interventional exchange
4
exchange left
4
left transvenous
4
lead
4
stimulation lead
4
lead novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!